Selected article for: "acute lung injury and clinical trial"

Author: Jin, Tianru; Liu, Mingyao
Title: Letter to the Editor: Comment on GLP-1-based drugs and COVID-19 treatment
  • Cord-id: nmix4cqh
  • Document date: 2020_5_26
  • ID: nmix4cqh
    Snippet: • GLP-1R is abundantly expressed in lung epithelia and certain immune cells. • GLP-1 based drugs show “therapeutic effects” in acute and chronic lung injury models. • Clinical trial is designed in testing effect of GLP-1 analogues in treating Covid-19. • Retrospective studies should be conducted in T2D subject with Covid-19.
    Document: • GLP-1R is abundantly expressed in lung epithelia and certain immune cells. • GLP-1 based drugs show “therapeutic effects” in acute and chronic lung injury models. • Clinical trial is designed in testing effect of GLP-1 analogues in treating Covid-19. • Retrospective studies should be conducted in T2D subject with Covid-19.

    Search related documents:
    Co phrase search for related documents